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Abstract
AIM 
To examine whether hemodialysis (HD) patients with 
restless legs syndrome (RLS) are subjects of greater 
fatigue and impaired quality of life (QoL) compared to HD 
patients without RLS.
METHODS
Eighty five stable HD patients participated in this study. 
According to their RLS status, the patients were divided 
World Journal of 
NephrologyW J N
Submit a Manuscript: http://www.f6publishing.com
DOI: 10.5527/wjn.v6.i5.236
World J Nephrol  2017 September 6; 6(5): 236-242
ISSN 2220-6124 (online)
Observational Study
237 September 6, 2017|Volume 6|Issue 5|WJN|www.wjgnet.com
Giannaki CD et al . Restless legs syndrome in hemodialysis patients
into the RLS group (n  = 23) and the non-RLS group (n 
= 62). QoL, fatigue, sleep quality, daily sleepiness and 
depression symptoms were assessed by using various 
questionnaires. Finally, biochemical parameters including 
iron, ferritin, hemoglobin, hematocrit and parathormone 
were assessed. 
RESULTS
The HD patients with RLS scored worse in all the 
questionnaires used in the study (P < 0.05). The patients 
with RLS were more likely to receive the HD therapy 
on the morning shift, whilst 43.5% of the RLS patients 
reported to experience the RLS symptoms also during 
HD. The severity of RLS was correlated with fatigue, 
depression score and sleep quality (P < 0.05). 
CONCLUSION
HD patients with RLS are subject to lower QoL related 
parameters and greater fatigue compared to HD patients 
without RLS. RLS should be successfully managed in order 
to improve the QoL of the sufferers.
Key words: Sleep quality; Depression; Secondary restless 
legs syndrome; Fatigue; Quality of life
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Core tip: Restless legs syndrome (RLS) is very common 
in patients receiving hemodialysis therapy. It seems that 
the hemodialysis patients who suffer also from RLS are 
subject of greater fatigue levels and they are experience 
even more impaired quality of life, sleep quality, daily 
sleepiness and depression symptoms compared to their 
free RLS counterparts. 
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INTRODUCTION
Restless legs syndrome (RLS) (also called as Willis-
Ekbom disease) is a sensory-motor sleep disorder which 
is very common in hemodialysis (HD) patients. It is 
called also as uremic RLS and it is affecting almost 30% 
of the HD population[1]. 
According to the literature, the symptoms’ severity 
of uremic RLS is worse compared to the idiopathic 
RLS[2], whilst a number of studies highlight the negative 
effects of this extremely distressing sleep disorder 
on many aspects of the patient’s quality of life (QoL), 
overall health and wellbeing[1]. 
In particular, data derived mainly from cross-
sectional studies reveal that the HD patients with RLS 
experience significantly poorer sleep quality[3], increased 
insomnia[4] and motor activity during sleep[5], higher 
depression symptoms[6], increased anxiety levels[7] 
and increased muscle atrophy[6] compared to HD 
patients without RLS. Moreover, RLS motor and sensory 
symptoms may appear also during HD therapy[8] 
inducing significant disturbance of the patient’s rest 
and patience. Therefore is not surprising that the HD 
patients with RLS are characterized by even poorer QoL 
levels compared to HD patients without RLS[1]. 
On the other hand, it is well known that the majority 
of the HD patients have significant levels of fatigue[9]. 
Fatigue experienced by the HD patients has both mental 
and physical aspects and could significantly affect the 
QoL levels of this specific population[10]. In the study by 
Jhamb et al[11], fatigue was independently associated, 
among others, with sleep quality and RLS.
The current study aimed to investigate potential 
differences in QoL, depression levels, sleep quality, 
fatigue and daily sleepiness status between HD pa-
tients with and without RLS. Taking into account the 
considerable negative effect of RLS on many physical 
and mental related parameters and especially on 
sleep, we hypothesize that the HD patients with RLS 
will present significantly greater fatigue and lower QoL 
levels compared to their free-RLS counterparts.
MATERIALS AND METHODS
Eighty-five out of 102 HD patients volunteer to par-
ticipate in this study. Patients were recruited from 
the HD units of the General Hospitals of Larnaca and 
Limassol, Cyprus. After a brief discussion of the purpose 
of the study and the procedures to be followed, the 
patients who voluntarily agreed to participate to the 
study and gave written informed consent included in the 
cohort. Inclusion criteria were as follows: Being in HD 
therapy 3 times per week at least 3 mo and with stable 
clinical condition. Patients received the HD therapy with 
the morning shift either with the noon shift, both using 
hollow-fiber dialysers and bicarbonate buffer. Exclusion 
criteria included treatment with dopamine agonists 
prior to the study and cognitive inability to complete the 
various questionnaires. 
RLS was diagnosed using the International RLS 
study group criteria[12], whilst RLS severity was assessed 
by using the International RLS Severity Scale (IRLS)[13]. 
Information related to when the first RLS symptoms 
appeared (before or after the institution of HD therapy), 
whether other members of the patients suffer also from 
RLS and whether the symptoms of RLS appear also 
during HD therapy were obtained also. 
All patients provided a written consent for par-
ticipation to the study, which conformed to the prin-
ciples enumerated in the Helsinki Declaration of 1975. 
The study was approved by the National Bioethics 
Committee of Cyprus. 
Questionnaires
QoL levels were evaluated using the SF-36 question-
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naire[14]. Fatigue levels were assessed by using the fatigue 
severity scale (FSS)[15]. The patients’ depression symptoms 
were assessed by using the self-rating depression scale 
developed by Zung[16]. Daily sleepiness status was 
assessed by using the Epworth Sleepiness Scale (ESS)[17]. 
Finally, the patients’ subjective sleep quality was assessed 
by the Pittsburgh sleep quality index (PSQI)[18]. 
Biochemical assessment
The patient’s routine monthly laboratory results were 
recorded including iron (photometry), ferritin (specto-
photometry, Beckman Coulter AU 680 Chemistry Analy-
zer), hematocrit, haemoglobin [sodium lauryl sulfate 
(SLS) method], albumin (photometry) and parathormone 
(chemiluminescence, ARCHITECT assay, Abbott Labo-
ratories, Wiesbaden, Germany). The biochemical analysis 
was performed at the clinical labs of the affiliated hospitals 
under standard hospital procedures.
Statistical analysis
The differences between the RLS and the non-RLS group 
in regards to the various variables were examined using 
independent samples t test. χ 2 tests were used in order 
to compare the two groups for categorical variables. 
The Pearson correlation test was used to assess the 
relationship between the examined variables. All data 
are presented as mean ± SD and the level of statistical 
significance was set at P < 0.05. All analyses were 
carried out using the SPSS Statistical Package version 
19. The statistical review of the study was performed by 
a biomedical statistician.
RESULTS
Twenty-three out of 84 patients (27%) were diagnosed 
to experience RLS symptoms, whilst 10 out of those 23 
RLS patients reported to experience the RLS symptoms 
also during HD (43.5%). Only 2 patients reported that a 
member of their family experience also RLS symptoms 
(8.7%), whereas 3 patients reported to experience 
the RLS symptoms before the institution of the HD 
treatment (13%).
The patients’ characteristics are presented in Table 
1. The patients with RLS were found to have lower 
hemoglobin levels (P = 0.022) compared to the patients 
without RLS. In addition, the patients with RLS were 
more likely to receive the HD therapy on the morning 
shift (P = 0.026).
Depression, fatigue, daytime sleepiness and sleep 
quality data are presented in Table 2. QoL data are 
presented in Table 3. All the examined parameters 
were found to be significantly worse in the RLS patients 
compared to the free-RLS patients (P < 0.05). Finally, 
the IRLS score positively correlated with PSQI (r = 0.477, 
P = 0.025), depression score (r = 0.551, P = 0.010) 
and fatigue index (r = 0.582, P = 0.004). 
DISCUSSION
The main finding of the current study is that the 
Table 1  Patient’s characteristics presented as pool data and divided in two groups according to restless legs syndrome diagnosis
Variables Patients pool data RLS Non-RLS P  value
n 85 23 62 -
Female/male 54/31 10/13 21/41    0.4141 
Age (yr)   67.3 ± 11.4 67.8 ± 9.6   67.1 ± 12.1   0.801
95%CI 64.8 to 69.8 63.6 to 73.0 64.1 to 70.2  
Weight (kg)   73.3 ± 15.9   77.3 ± 20.4   72.0 ± 14.1   0.205
95%CI 67.5 to 87.2 68.3 to 75.7
Dialysis shift morning/noon 54/31 4/19 35/27    0.0261
Years in hemodialysis   4.7 ± 5.1   5.2 ± 4.9   4.5 ± 5.2   0.592
95%CI 3.6 to 5.8 3.1 to 7.3 3.2 to 5.9
IRLS score - 21.8 ± 6.1 - -
95%CI 19.1 to 24.5
Iron (μg/dL)   44.7 ± 18.2   43.0 ± 16.6   45.4 ± 19.0   0.741
95%CI 38.2 to 51.2 30.2 to 55.7 37.3 to 53.4
Ferritin (ng/mL)   514.4 ± 411.7   443.7 ± 356.5   547.4 ± 441.5   0.567
95%CI 344.4 to 684.3 145.6 to 741.8 320.4 to 774.6
Hct 36.4 ± 5.3 33.9 ± 5.6 37.7 ± 4.9   0.111
95%CI 34.2 to 38.7 29.2 to 38.7 35.1 to 40.3
Hb (g/dL) 11.1 ± 1.5 10.1 ± 1.6 11.4 ± 1.4   0.022
95%CI 10.5 to 11.6 8.9 to 11.3 10.8 to 12.0
Parathormone (pmol/L)   4.9 ± 1.9   4.8 ± 1.7   4.9 ± 2.0 0.97
95%CI 4.2 to 5.5 3.6 to 6.1 4.0 to 5.8
Albumin (g/dL)   3.6 ± 0.3   3.6 ± 0.3   3.6 ± 0.3   0.853
95%CI 3.5 to 3.8 3.4 to 3.9 3.5 to 3.8
Diabetes (%) 30 (35.3) 9 (39.1) 21 (33.9)    0.7651
Hypertension (%) 30 (35.3 ) 8 (34.8) 22 (35.5)    0.8321
1For categorical data a χ 2 test performed. All data are mean ± SD (95%CI). IRLS: International restless legs syndrome severity scale; Hct: Hematocrit; Hb: 
Hemoglobin.
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HD patients who suffer also from RLS are subject of 
greater fatigue levels and they are experience even 
more impaired QoL, sleep quality, daily sleepiness and 
depression symptoms compared to HD patients without 
RLS. 
Many factors could contribute to the increased fati-
gue levels of the HD patients. Recent studies indicate 
sleep disorders as one of the major factors which may 
be responsible for the elevated fatigue levels of the HD 
patients[10]. Interestingly, in line with our findings, RLS 
has been reported to associate with greater fatigue 
levels in patients on HD[11]. 
RLS is a sleep disorder which is highly prevalent 
in the HD population[1]. Approximately 27% of the 
studied patients were diagnosed to experience RLS 
symptoms; a prevalence which is in line with the pu-
blished literature in the field[1]. We should note that 
those are the first data regarding RLS from Cyprus. 
In addition, approximately 43.5% of the RLS patients 
reported to experience the RLS symptoms during 
HD therapy, factor that may contribute to increase 
fatigability of the patients during their treatment. On 
the other hand, the findings of the current study reveal 
that the patients with RLS have significantly worse daily 
sleepiness status, in line with previous findings[7,19]. 
Daily sleepiness has been shown to be associated with 
fatigue in patients receiving HD therapy[11]. Finally, 
the data of the current study confirm the well known 
negative effect of uremic RLS on sleep quality[1,4], whilst 
the severity of RLS was correlated with poor sleep 
quality. 
Taking into consideration the fact that many HD 
patients experience elevated fatigue symptoms[9,20] and 
the fact that RLS may contribute to even greater fatigue 
symptoms, successful management of RLS may help 
those patients to reduce among others also fatigue and 
Table 2  Depression, fatigue, daytime sleepiness and sleep quality data presented as pool data and divided in two groups according 
to restless legs syndrome diagnosis
Variables Patients pool data RLS Non-RLS P  value
Pittsburgh sleep quality index   7.8 ± 5.1  13.9 ± 2.9   5.5 ± 3.6 0.000
95%CI 6.6 to 7.9 12.6 to 15.2 4.6 to 6.5
Epworth sleepiness scale    4.3 ± 3.6   6.8  ± 4.3   3.4 ± 2.8 0.000
95%CI 3.5 to 5.1 4.9 to 8.7 2.6 to 4.1
Zung depression scale  60.8 ± 7.1  58.0 ± 4.0 48.3 ± 6.1 0.000
95%CI 49.2 to 52.4 56.1 to 59.8 46.7 to 49.9
Fatigue severity scale index   4.5 ± 1.2    5.8 ± 0.7   4.1 ± 1.1 0.000
95%CI 4.3 to 4.8 5.4 to 6.1 3.8 to 4.3
All data are mean ± SD (95%CI). RLS: Restless legs syndrome.
Table 3  Quality of life data presented as pool data and divided in two groups according to restless legs syndrome diagnosis
Variables Patients pool data RLS Non-RLS P  value
SF-36 MCS  55.3 ± 16.7  46.6 ± 15.4 58.5 ± 16.1 0.004
95%CI 51.6 to 59.0 39.8 to 53.5 54.3 to 62.7
SF-36 PCS  51.8 ± 19.4  40.6 ± 18.1 56.1 ± 18.2 0.001
95%CI 47.5 to 56.1 32.5 to 48.6 51.2 to 60.8
SF-36 total score 55.1 ± 18.8  45.5 ± 17.7 58.7 ± 18.1 0.004
95%CI 51.0 to 59.3 37.6 to 53.3 54.0 to 63.4
Physical function 46.9 ± 29.1  38.4 ± 28.2 50.1 ± 29.1 0.107
95%CI 40.5 to 53.4 25.8 to 50.9 42.5 to 57.7
Role physical 45.3 ± 42.4  28.4 ± 38.8 51.6 ± 42.2 0.027
95%CI 35.9 to 54.7 11.2 to 45.6 40.6 to 42.7
Body pain 72.3 ± 23.1  63.9 ± 24.3 75.4 ± 22.0 0.045
95%CI 67.1 to 77.4 53.1 to 74.7 69.6 to 81.1
General health 47.0 ± 16.4  37.1 ± 14.5 50.7 ± 15.6 0.001
95%CI 43.4 to 50.6 30.6 to 43.5 46.6 to 54.8
Vitality 48.3 ± 16.1  36.1 ± 14.5 52.8 ± 14.2 0.000
95%CI 44.7 to 51.8 29.6 to 42.5 49.1 to 56.6
Social functioning 71.8 ± 20.8  65.5 ± 21.7 74.1 ± 20.2 0.098
95%CI 67.2 to 76.4 55.9 to 75.1 68.9 to 79.4
Mental health 52.2 ± 45.3  43.9 ± 47.5 55.3 ± 44.4 0.316
95%CI 42.2 to 62.3 22.8 to 65.0 43.7 to 66.9
Reported health 57.1 ± 12.1  50.7 ± 10.7 59.5 ± 11.8 0.003
95%CI 54.4 to 59.8 45.9 to 55.4 56.4 to 62.6
All data are mean ± SD (95%CI). SF-36: 36-Item Short Form Health Survey; MCS: Mental component score; PCS: Physical component score; RLS: Restless 
legs syndrome.
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tiredness feelings. It is known that exercise training 
alone[21-23] or in combination with dopamine agonists[24] 
could ameliorate the severity of uremic RLS symptoms. 
On the other hand, evidence exists regarding the 
favorable effect of exercise training on fatigue levels of 
HD patients, however, RLS presence was not taken into 
consideration in these studies[20]. It would be interesting 
in future studies to investigate the effects of chronic 
exercise training on fatigue levels in patients with 
uremic RLS.
Morning-shift HD was found to associated with RLS, 
in contrast with previous studies[25,26], however, we 
should note that the association between the time of 
HD delivery and RLS is still controversial. In addition, 
hemoglobin levels observed to be significantly lower in 
the RLS group, confirming previous data[27]. Notably, 
low haemoglobin levels may contribute to greater levels 
of fatigue in the HD population[28]. However, we should 
note that many cross-sectional studies did not confirm 
an association between lower hemoglobin levels and 
RLS presence in HD patients[6]. 
According to the literature, familiar component 
appear to be high in idiopathic RLS[29]. In contrast, 
familial component reported to be significantly lower 
in patients with uremic RLS compared to idiopathic 
RLS[30]. In the current study, approximately 9% of the 
RLS patients reported that a member of their family 
experience also RLS symptoms, in line with previous 
data which reported similar prevalence[30]. In addition, 
13% of the RLS patients reported that they were 
experience the RLS symptoms before the start of the 
HD treatment, showing the association of renal disease 
and RLS. Interestingly, the RLS symptoms have been 
reported to ameliorated or disappeared after kidney 
transplantation[31]. Moreover, no gender differences 
were found in regards to the RLS presence in our stu-
dy, confirming previous studies[32], and in contrast to 
others[27]. 
Diabetes prevalence did not differ between groups. It 
is known that RLS has been linked to various diseases, 
including diabetes and hypertension[33]. In the current 
study no such an association was found between RLS 
presence and diabetes and hypertension presence. 
Depression score was found to be significantly worse 
in the patients with RLS compared to the patients without 
RLS, confirming previous studies the RLS group[6,34]. 
Moreover, depression score was correlated with the 
severity of RLS. The depressing effect of RLS on various 
parameters which are known to affect fatigue levels in 
HD patients such as sleep, QoL and depression[20,35] and 
the distressful nature of the syndrome itself may explain 
the higher depression score of the patients of the RLS 
group. 
In conclusion, the findings of the current study con-
firm the negative effect of RLS on many aspects of 
QoL, including greater fatigue levels. Measures should 
be taken in order to manage the RLS symptoms and 
improve the QoL and general health of the patients with 
uremic RLS. 
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